﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ReachMD CME</title><link>http://www.reachmd.com/cme.aspx</link><description>Providing Medical Knowledge on Demand.  Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD XM160, or on your computer at ReachMD.com or download and use the ReachMD iPhone app and earn CME credit at your convenience.</description><copyright>Copyright 2012 ReachMD. All rights reserved.</copyright><atom:link href="http://www.reachmd.com/rss/cme.aspx" rel="self" type="application/rss+xml" /><item><title><![CDATA[Genetic Profiling in Early-Stage Breast Cancer<br><i>Part 2 of 2</i>]]></title><description><![CDATA[<p>CME credits: 0.25 - <i>AMA PRA Category 1 Credit(s)<sup>TM</sup></i><br/>Valid until: 01/23/2013<br/>Faculty: Terry P. Mamounas, MD</p><p>Hosted by: Matthew Birnholz, MD</p><p>Program Description:<br/><p>This curriculum is designed to improve the management of early-stage breast cancer. The focus is to 1) improve physician decision-making when incorporating treatment algorithms into their clinical practice; 2) evaluate the "value propositions" for genomic/biomarker assays when making treatment decisions; and 3) identify improved treatment options for women with triple negative disease to offer them better outcomes for this difficult to treat subset of early-stage breast cancer.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6554</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6554</guid><pubDate>Mon, 23 Jan 2012 06:00:00 GMT</pubDate><category>Oncology - Hematology</category><category>Clinical Medicine</category></item><item><title><![CDATA[Pri-Med Access with American College of Physicians Series:<br>Calcium and Vitamin D]]></title><description><![CDATA[<p>CME credits: 0.50<br/>Valid until: 12/28/2012<br/>Faculty: Jerry Yee, MD </p><p>Hosted by: Mark Chyna, MD</p><p>Program Description:<br/><p>Pri-Med introduces "Pri-Med Access with ACP on ReachMD"; a new interview series with leading faculty live from the event.  Now you can access exclusive highlights from the program on-demand anytime, anywhere both online and via your mobile device with Pri-Med Access with ACP on ReachMD.  Tune in each week to listen to the latest episode.  Topics include neurologic work ups, anemia,  thyroid disease, dermatology diagnoses, vitamin D metabolism and deficiencies, top literature highlights, and more.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6510</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6510</guid><pubDate>Wed, 28 Dec 2011 06:00:00 GMT</pubDate><category>General Medicine and Primary Care</category><category>Clinical Medicine</category></item><item><title><![CDATA[Pri-Med Access with American College of Physicians Series: <br>Managing Concussion]]></title><description><![CDATA[<p>CME credits: 0.50<br/>Valid until: 12/28/2012<br/>Faculty: Neil Skolnik, MD</p><p>Hosted by: Mark Chyna, MD</p><p>Program Description:<br/><p>Pri-Med introduces "Pri-Med Access with ACP on ReachMD"; a new interview series with leading faculty live from the event.  Now you can access exclusive highlights from the program on-demand anytime, anywhere both online and via your mobile device with Pri-Med Access with ACP on ReachMD.  Tune in each week to listen to the latest episode.  Topics include neurologic work ups, anemia,  thyroid disease, dermatology diagnoses, vitamin D metabolism and deficiencies, top literature highlights, and more.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6508</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6508</guid><pubDate>Wed, 28 Dec 2011 06:00:00 GMT</pubDate><category>Sports Medicine</category><category>Clinical Medicine</category></item><item><title><![CDATA[Prevention of Pneumococcal Disease in Children]]></title><description><![CDATA[<p>CME credits: 0.25 - <i>AMA PRA Category 1 Credit(s)<sup>TM</sup></i><br/>Valid until: 12/16/2012<br/>Faculty: Stephen I. Pelton, MD</p><p>Hosted by: Lee Freedman, MD</p><p>Program Description:<br/><p>Infection with <em>Streptococcus pneumoniae</em> bacteria is reported by the CDC as a leading cause of illness in young children. Before routine use of pneumococcal conjugate vaccine, pneumococcal infection caused meningitis, blood infections, ear infections and approximately 200 deaths in the US annually in children under five. The pneumococcal conjugate vaccine (PCV13) protects against 13 of the 90 types of pneumococcal bacteria and is given to infants and toddlers to protect them when they are at greatest risk.  The Advisory Committee on Immunization Practices (ACIP) has recommended that pneumococcal conjugate vaccine (PCV13) be used more for all children aged 2-59 months, for children aged 60-71 months with underlying medical conditions that increase their risk for pneumococcal disease or complications and for children at high risk from 6 through 18 years of age. This course identifies the current disease burden associated with pneumococcal disease, the importance of pneumococcal colonization in disease, and details the importance for healthcare providers to adopt the updated guideline recommendations in their clinical practice.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6532</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6532</guid><pubDate>Fri, 16 Dec 2011 06:00:00 GMT</pubDate><category>Pediatrics</category><category>Clinical Medicine</category></item><item><title><![CDATA[<i>Clostridium difficile</i> Infection: From Diagnosis to Evolving Treatments]]></title><description><![CDATA[<p>CME credits: 0.75<br/>Valid until: 10/28/2012<br/>Faculty: Stuart  Johnson, MD, DTM&H, Stuart Cohen, MD, FACP, FIDSA</p><p>Hosted by: Stuart Cohen, MD, FACP, FIDSA</p><p>Program Description:<br/><p>Rates of <em>Clostridium difficile</em> Infection (CDI) incidence, hospitalizations, and deaths have been increasing in recent years, suggesting that current management of this condition may be suboptimal.<sup>1</sup> A number of factors may be attributed to inadequate management of this condition, including controversies regarding optimal diagnostic testing for CDI, risk factors for initial disease and recurrence, and suboptimal adherence to guidelines for infection control strategies.<sup>2-5 </sup>Given the recent updated guidelines for CDI, combined with several new agents in development for this disease, it is important that healthcare professionals be aware of the most current research and recommendations for the management of CDI.</p>
<p><strong>References:</strong><br />1 Zilberberg MD, et al. <em>Emerg Infect Dis</em>. 2008;14:929-931.<br />2 Hansen G, et al. <em>Clinical Laboratory News.</em> 2010;36:10-13.<br />3 Association for Professionals in Infection Control (APIC) Pace of Progress poll. May 2010.<br />4 Gravel D, et al. <em>Am J Infect Control.</em> 2009;37:9-14.<br />5 Byker GL, et al. <em>Infect Control Hosp Epidemiol.</em> 2009;30:397-399.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6545</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6545</guid><pubDate>Fri, 28 Oct 2011 05:00:00 GMT</pubDate><category>HIV/AIDS and Infectious Disease</category><category>Clinical Medicine</category></item><item><title><![CDATA[Pri-Med Access with American College of Physicians Series:<br>Game-based educational activities: are they a valid format for physician learning?]]></title><description><![CDATA[<p>CME credits: 0.00<br/>Valid until: 09/23/2012<br/>Faculty: Marie T. Brown, MD, FACP</p><p>Hosted by: Matt Sorrentino, MD</p><p>Program Description:<br/><p>Pri-Med introduces "Pri-Med Access with ACP on ReachMD"; a new expert interview series with leading faculty live from the event.  Now you can access exclusive highlights from the program on-demand anytime, anywhere both online and via your mobile device with Pri-Med Access with ACP on ReachMD.  Tune in each week to listen to the latest episode.  Topics include neurologic work ups, anemia, thyroid disease, dermatology diagnoses, vitamin D metabolism and deficiencies, top literature highlights, and more.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6513</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6513</guid><pubDate>Fri, 23 Sep 2011 05:00:00 GMT</pubDate><category /></item><item><title><![CDATA[Pri-Med Access with American College of Physicians Series:<br>Combining Clopidogrel and Proton Pump Inhibitors: What Do the Data Really Say?]]></title><description><![CDATA[<p>CME credits: 0.50<br/>Valid until: 09/02/2012<br/>Faculty: Kelly Anne Spratt, DO, FACP, FACC</p><p>Hosted by: Matt Sorrentino, MD</p><p>Program Description:<br/><p>Pri-Med introduces "Pri-Med Access with ACP on ReachMD"; a new expert interview series with leading faculty live from the event.  Now you can access exclusive highlights from the program on-demand anytime, anywhere both online and via your mobile device with Pri-Med Access with ACP on ReachMD.  Tune in each week to listen to the latest episode.  Topics include neurologic work ups, anemia, thyroid disease, dermatology diagnoses, vitamin D metabolism and deficiencies, top literature highlights, and more.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6512</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6512</guid><pubDate>Fri, 02 Sep 2011 05:00:00 GMT</pubDate><category>Cardiology</category><category>Clinical Medicine</category></item><item><title><![CDATA[Tailoring the Treatment of Chronic Constipation in Older Adults]]></title><description><![CDATA[<p>CME credits: 0.50<br/>Valid until: 06/30/2012<br/>Faculty: John F. Johanson, MD, MSc, FACP, FACG, Louis Kuritzky, MD</p><p>Hosted by: Matt Sorrentino, MD</p><p>Program Description:<br/><p>Chronic constipation is not a trivial condition; it can dramatically impact quality of life and lead to serious medical problems. The estimated prevalence of chronic constipation in the U.S. is between 2 and 27%, but this increases to 40% among people over 65 years of age. Older adults are at particular risk due to additional chronic disease burdens, immobility, and/or functional limitations. <br /><br />Chronic constipation can be diagnosed when a patient is experiencing fewer than 3 bowel movements per week and at least two of the following are present in at least 25% of defecations for a period of 3 months or more: hard or lumpy stools, straining with defecation, a sensation of incomplete evacuation, a sensation of anorectal obstruction, or the use of manual maneuvers to assist defecation.<br /><br />Recognizing chronic constipation can be a challenge, due in large part to a significant disconnect between patient and clinician perceptions of constipation. Effective management of chronic constipation requires a combination of provider and patient education, lifestyle and/or pharmacologic modifications, and the judicious use of pharmacologic and nonpharmacologic therapies. <br /><br />This podcast will review approaches to care, describe management pitfalls, and outline considerations for tailoring treatment for individual patients. With an improved understanding of the condition and its management, primary, geriatric, and long-term care providers can help lessen the burden of chronic constipation and significantly improve the lives of the older adults in their care.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6464</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6464</guid><pubDate>Thu, 30 Jun 2011 05:00:00 GMT</pubDate><category>Gastroenterology</category><category>Clinical Medicine</category></item><item><title><![CDATA[Prevention of Pneumococcal Disease in Children:<br><i>Optimizing Vaccine Strategies</i>]]></title><description><![CDATA[<p>CME credits: 0.50 - <i>AMA PRA Category 1 Credit(s)<sup>TM</sup><br/>Valid until: 04/28/2012<br/>Faculty: Stephen I. Pelton, MD</p><p>Hosted by: Jennifer Shu, MD</p><p>Program Description:<br/><p>Infection with <em>Streptococcus pneumoniae</em> bacteria is reported by the CDC as a leading cause of illness in young children. Before routine use of pneumococcal conjugate vaccine, pneumococcal infection caused meningitis, blood infections, ear infections and approximately 200 deaths in the US annually in children under five. The pneumococcal conjugate vaccine (PCV13) protects against 13 of the 90 types of pneumococcal bacteria and is given to infants and toddlers to protect them when they are at greatest risk.  The Advisory Committee on Immunization Practices (ACIP) has recommended that pneumococcal conjugate vaccine (PCV13) be used more for all children aged 2-59 months, for children aged 60-71 months with underlying medical conditions that increase their risk for pneumococcal disease or complications and for children at high risk from 6 through 18 years of age. This course identifies the current disease burden associated with pneumococcal disease, the importance of pneumococcal colonization in disease, and details the importance for healthcare providers to adopt the updated guideline recommendations in their clinical practice.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6154</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6154</guid><pubDate>Thu, 28 Apr 2011 05:00:00 GMT</pubDate><category>Pediatrics</category><category>Clinical Medicine</category></item><item><title><![CDATA[Part 3 of 3: Sound Strategies for the Prevention of Venous Thromboembolism]]></title><description><![CDATA[<p>CME credits: 0.50 - <i>AMA PRA Category 1 Credit(s)<sup>TM</sup></i><br>CPE: 0.50 ACPE Contact Hours <br>CNE: 0.50 ANCC Contact Hours<br/>Valid until: 04/13/2012<br/>Faculty: Vincent Pellegrini, Jr., MD, Robert Pendleton, MD</p><p>Hosted by: Lee Freedman, MD</p><p>Program Description:<br/><p>Venous thromboembolism (VTE) is a common cardiovascular illness affecting over 1 million Americans each year.  Despite advances in drug therapy, this largely preventable disease continues to result in high rates of morbidity and mortality, highlighting the need for proactive identification of at risk individuals.  Reviewing evidence-based recommendations for prevention and treatment of VTE and discussing emerging therapies is highly important for a broad range of healthcare providers across a variety of settings.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6281</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6281</guid><pubDate>Wed, 13 Apr 2011 05:00:00 GMT</pubDate><category>Cardiology</category><category>Clinical Medicine</category></item><item><title><![CDATA[Part 2 of 3: Sound Strategies for the Prevention of Venous Thromboembolism]]></title><description><![CDATA[<p>CME credits: 0.50 - <i>AMA PRA Category 1 Credit(s)<sup>TM</sup></i><br>CPE: 0.50 ACPE Contact Hours <br>CNE: 0.50 ANCC Contact Hours<br/>Valid until: 04/12/2012<br/>Faculty: Clifford W. Colwell, Jr., MD, Geno J. Merli, MD, FACP</p><p>Hosted by: Mark Chyna, MD</p><p>Program Description:<br/><p>Venous thromboembolism (VTE) is a common cardiovascular illness affecting over 1 million Americans each year.  Despite advances in drug therapy, this largely preventable disease continues to result in high rates of morbidity and mortality, highlighting the need for proactive identification of at risk individuals.  Reviewing evidence-based recommendations for prevention and treatment of VTE and discussing emerging therapies is highly important for a broad range of healthcare providers across a variety of settings.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6282</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6282</guid><pubDate>Tue, 12 Apr 2011 05:00:00 GMT</pubDate><category>Cardiology</category><category>Clinical Medicine</category></item><item><title><![CDATA[Part 1 of 3: Sound Strategies for the Prevention of Venous Thromboembolism]]></title><description><![CDATA[<p>CME credits: 0.50 - <i>AMA PRA Category 1 Credit(s)<sup>TM</sup></i><br>CPE: 0.50 ACPE Contact Hours <br>CNE: 0.50 ANCC Contact Hours<br/>Valid until: 04/11/2012<br/>Faculty: Steven M. Berkowitz, MD, Marc A. Passman, MD</p><p>Hosted by: Lee Freedman, MD</p><p>Program Description:<br/><p>Venous thromboembolism (VTE) is a common cardiovascular illness affecting over 1 million Americans each year.  Despite advances in drug therapy, this largely preventable disease continues to result in high rates of morbidity and mortality, highlighting the need for proactive identification of at risk individuals.  Reviewing evidence-based recommendations for prevention and treatment of VTE and discussing emerging therapies is highly important for a broad range of healthcare providers across a variety of settings.</p></p>]]></description><link>http://www.reachmd.com/cmedetails.aspx?sid=6280</link><guid>http://www.reachmd.com/cmedetails.aspx?sid=6280</guid><pubDate>Mon, 11 Apr 2011 05:00:00 GMT</pubDate><category>Cardiology</category><category>Clinical Medicine</category></item></channel></rss>
